# Montelukast Sodium

NDC: 43063-381
Generic name: Montelukast Sodium
Labeler / Manufacturer: PD-Rx Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, CHEWABLE
Routes: ORAL
Marketing started: 20120803

FDA application: ANDA090984

## Active ingredients

- MONTELUKAST SODIUM: 4 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"43063-381"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=43063-381
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=c69ab399-8ea6-4002-9271-b6a57c862b14